vimarsana.com
Home
Live Updates
Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress : comparemela.com
Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress
HOUSTON, May 16, 2024 /PRNewswire/ -- Moleculin Biotech, Inc., , a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today...
Related Keywords
Madrid ,
Spain ,
Houston ,
Texas ,
United States ,
Jenene Thomas ,
Wolframcm Dempke ,
Nasdaq ,
Facebook ,
Moleculin Biotech Inc ,
Prnewswire Moleculin Biotech Inc ,
Linkedin ,
Twitter ,
European Chief Medical Officer ,
Moleculin Biotech ,
Transcription Modulator ,
comparemela.com © 2020. All Rights Reserved.